BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15975406)

  • 1. Clonal light chain restricted primary intrapulmonary nodular amyloidosis.
    Ross P; Magro CM
    Ann Thorac Surg; 2005 Jul; 80(1):344-7. PubMed ID: 15975406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary light chain deposition disease: report of five cases and review of the literature.
    Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
    Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
    Grogg KL; Aubry MC; Vrana JA; Theis JD; Dogan A
    Am J Surg Pathol; 2013 Mar; 37(3):406-12. PubMed ID: 23282974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse parenchymal amyloidosis of lungs and breast. Its association with diffuse plasmacytosis and kappa-chain gammopathy.
    Hardy TJ; Myerowitz RL; Bender BL
    Arch Pathol Lab Med; 1979 Oct; 103(11):583-5. PubMed ID: 114145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary manifestations of light chain deposition disease.
    Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
    Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis.
    Perfetti V; Ubbiali P; Magni M; Colli Vignarelli M; Casarini S; Matteucci P; Gianni AM; Merlini G
    Bone Marrow Transplant; 1999 Feb; 23(4):323-7. PubMed ID: 10100575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica -- a clue to an underlying monoclonal gammopathy.
    Cioc AM; Frambach GE; Magro CM
    J Cutan Pathol; 2005 Apr; 32(4):263-7. PubMed ID: 15769274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis.
    Manske MK; Zuckerman NS; Timm MM; Maiden S; Edelman H; Shahaf G; Barak M; Dispenzieri A; Gertz MA; Mehr R; Abraham RS
    Clin Immunol; 2006 Jul; 120(1):106-20. PubMed ID: 16515886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
    Gertz MA; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Kyle RA
    Haematologica; 2008 Sep; 93(9):1402-6. PubMed ID: 18641023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic light chain amyloidosis - molecular basis and clinical perspectives].
    Schönland SO; Moos M; Bochtler T; Ho AD; Hegenbart U
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1949-52. PubMed ID: 19760558
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review.
    Ladha SS; Dyck PJ; Spinner RJ; Perez DG; Zeldenrust SR; Amrami KK; Solomon A; Klein CJ
    J Peripher Nerv Syst; 2006 Dec; 11(4):346-52. PubMed ID: 17117943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-chain (AL) amyloidosis: diagnosis and treatment.
    Sanchorawala V
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.
    Khoor A; Myers JL; Tazelaar HD; Kurtin PJ
    Am J Clin Pathol; 2004 Feb; 121(2):200-4. PubMed ID: 14983932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes.
    Sanchorawala V; Blanchard E; Seldin DC; O'Hara C; Skinner M; Wright DG
    Am J Hematol; 2006 Sep; 81(9):692-5. PubMed ID: 16795060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment.
    Gono T; Yazaki M; Fushimi T; Suzuki T; Uehara T; Sano K; Kametani F; Ito N; Matsushita M; Nakamura S; Hoshii Y; Matsuda M; Ikeda S
    Am J Kidney Dis; 2006 May; 47(5):908-14. PubMed ID: 16632032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nodular pulmonary amyloidosis].
    Walther-Larsen S; Hansen U
    Ugeskr Laeger; 1990 Feb; 152(8):532-3. PubMed ID: 2309362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdiaphragmatic amyloidoma.
    Rosen DJ; Stavropoulos C; Travis WD; Ashton RC; Bhora FY; Connery CP
    Ann Thorac Surg; 2008 Jul; 86(1):310-2. PubMed ID: 18573451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular pulmonary light chain deposition disease.
    Yee M; Delahunt B; Russell PA
    Pathology; 2016 Aug; 48(5):515-8. PubMed ID: 27306574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.